LG
Liam Grover
Co-founder, Healome Therapeutics · Birmingham
University of Birmingham spinout developing an eye-drop matrix that forms a protective bandage for ocular surface diseases.
- Company
- Healome Therapeutics
- Sector
- Tech › Biotech
- Funding
- £2m oversubscribed seed led by Empirical Ventures (2026)
- Based in
- Birmingham
- Status
- active
- Now
- Head of the School of Chemical Engineering
Liam Grover in the press
- West Midlands Combined Authority backs spin-out with breakthrough technology for eye diseasesUniversity of Birmingham · 2026-09-01
- Healome Therapeutics Raises £2 Million Seed Round To Advance Eye-Drop Matrix Technology For Ocular Surface DiseasesPulse 2.0 · 2026-07-09
More biotech founders in Birmingham
Photo: University of Birmingham